Huanling Zhu

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Jianxiang Wang, Zhixiang Shen, Giuseppe Saglio et al. · Blood · 2015 · 108 citations · Full text

Potential role of exosome-associated microRNA panels and <i>in vivo</i> environment to predict drug resistance for patients with multiple myeloma

Li Zhang, Ling Pan, Bing Xiang et al. · Oncotarget · 2016 · 104 citations · Full text

Exosome-associated Microrna Panels, Pathology, Extracellular Microvesicles +20

Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy

H.-R. Li, J.-J. Huang, Hongpu Guo et al. · Journal of Viral Hepatitis · 2010 · 92 citations

Lymphoid Neoplasia, Hepatitis B Reactivation, Hepatology +14

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Qian Jiang, Zongru Li, Ya‐Zhen Qin et al. · Journal of Hematology & Oncology · 2022 · 90 citations · Full text

Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant

Xiao‐Jun Huang, Huan Chen, Mingzhe Han et al. · Biology of Blood and Marrow Transplantation · 2012 · 77 citations · Full text

Antifungal Agent, Transplantation, Antifungal Agents +10